Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus

被引:8
作者
Hirai, Hiroyuki [1 ]
Midorikawa, Sanae [1 ,2 ]
Suzuki, Shinichi [3 ]
Sasano, Hironobu [4 ]
Watanabe, Tsuyoshi [1 ]
Satoh, Hiroaki [1 ]
机构
[1] Fukushima Med Univ, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Fukushima, Japan
[2] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima, Japan
[3] Fukushima Med Univ, Dept Thyroid & Endocrinol, Sch Med, Fukushima, Japan
[4] Tohoku Univ, Dept Pathol, Grad Sch Med, Sendai, Miyagi 980, Japan
关键词
pheochromocytoma; secondary diabetes; urine c-peptide; catecholamine; somatostatin; IMMUNOREACTIVE SOMATOSTATIN; HORMONE; KETOACIDOSIS; PARAGANGLIOMA; POLYPEPTIDE; RELEASE; TUMOR; CELL;
D O I
10.2169/internalmedicine.55.7071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We herein present the findings of a 42-year-old woman with either adrenal pheochromocytoma or intraadrenal paraganglioma that simultaneously secreted somatostatin, thus mimicking insulin-dependent diabetes mellitus. Pheochromocytoma was clinically diagnosed based on scintigraphy, elevated catecholamine levels, and finally a histopathological analysis of resected specimens. The patient had diabetic ketosis, requiring 40 U insulin for treatment. Following laparoscopic adrenalectomy, insulin therapy was discontinued and the urinary c-peptide levels changed from 5.5-9.0 to 81.3-87.0 mu g/day. Histologically, somatostatin immunoreactivity was detected and the somatostatin levels were elevated in the serum-like fluid obtained from the tumor. Clinicians should be aware of the possible occurrence of simultaneous ectopic hormone secretion in patients with pheochromocytoma.
引用
收藏
页码:2985 / 2991
页数:7
相关论文
共 30 条
  • [1] HYPOGLYCEMIA INDUCED BY EXCESSIVE REBOUND SECRETION OF INSULIN AFTER REMOVAL OF PHEOCHROMOCYTOMA
    AKIBA, M
    KODAMA, T
    ITO, Y
    OBARA, T
    FUJIMOTO, Y
    [J]. WORLD JOURNAL OF SURGERY, 1990, 14 (03) : 317 - 324
  • [2] BEARD CM, 1983, MAYO CLIN PROC, V58, P802
  • [3] CRYER PE, 1993, INT J OBESITY, V17, pS43
  • [4] CRYER PE, 1993, INT J OBES RELAT S3, V17, pS68
  • [5] Pheochromocytoma presenting as diabetic ketoacidosis
    Douma, Stella
    Petidis, Konstantinos
    Kartali, Nikoleta
    Mahera, Konstantina
    Sabanis, Christos
    Zamboulis, Chrysanthos
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2008, 22 (04) : 295 - 296
  • [6] SOMATOSTATINOMA - SOMATOSTATIN-CONTAINING TUMOR OF ENDOCRINE PANCREAS
    GANDA, OP
    WEIR, GC
    SOELDNER, JS
    LEGG, MA
    CHICK, WL
    PATEL, YC
    EBEID, AM
    GABBAY, KH
    REICHLIN, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (17) : 963 - 967
  • [7] PREVENTION OF HUMAN DIABETIC KETOACIDOSIS BY SOMATOSTATIN - EVIDENCE FOR AN ESSENTIAL ROLE OF GLUCAGON
    GERICH, JE
    LORENZI, M
    BIER, DM
    SCHNEIDER, V
    TSALIKIAN, E
    KARAM, JH
    FORSHAM, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (19) : 985 - 989
  • [8] Adrenal and Extra-Adrenal Nonfunctioning Composite Pheochromocytoma/Paraganglioma with Immunohistochemical Ectopic Hormone Expression: Comparison of Two Cases
    Gong, Jing
    Wang, Xinxin
    Chen, Xueqin
    Chen, Ni
    Huang, Rui
    Lu, Changli
    Chen, Daiyun
    Zeng, Hao
    Zhou, Qiao
    [J]. UROLOGIA INTERNATIONALIS, 2010, 85 (03) : 368 - 372
  • [9] PANCREATIC ALPHA-CELL AND BETA-CELL FUNCTION IN PHEOCHROMOCYTOMA
    HAMAJI, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (03) : 322 - 325
  • [10] PHEOCHROMOCYTOMA AND DIABETES-MELLITUS - FURTHER EVIDENCE THAT ALPHA-2-RECEPTORS INHIBIT INSULIN RELEASE IN MAN
    ISLES, CG
    JOHNSON, JK
    [J]. CLINICAL ENDOCRINOLOGY, 1983, 18 (01) : 37 - 41